Can a better HER2 test predict who responds to targeted therapy?
NCT ID NCT06551116
First seen Jun 25, 2026 · Last updated Jul 09, 2026 · Updated 3 times
Summary
This study is testing a new, more precise method to measure HER2 levels in leftover tumor tissue from people with HER2-low metastatic breast cancer. The goal is to see if this test can accurately tell who will respond to the drug T-Dxd. Researchers will enroll 200 participants and compare the test results with actual treatment outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- quantitative HER2 assay (diagnostic test on leftover tumor tissue)
- What this could lead to
- If successful, this could lead to a more accurate test that helps doctors identify which patients with HER2-low breast cancer will benefit from targeted therapy like T-Dxd.
- What could go wrong
- This is an early diagnostic study, not a treatment trial. The test may not reliably predict response, and results may not change patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Email: •••••@•••••
-
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
RECRUITINGHouston, Texas, 77054, United States
-
Ben Taub General Hospital
RECRUITINGHouston, Texas, 77030, United States
-
Georgetown University - Lombardi CCC
RECRUITINGWashington D.C., District of Columbia, 20007, United States
-
John's Hopkins Hospital
RECRUITINGBaltimore, Maryland, 21287, United States
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77079, United States
-
MD Anderson Cancer Center
RECRUITINGSugar Land, Texas, 77478, United States
-
MD Anderson Cancer center
RECRUITINGHouston, Texas, 77030, United States
-
MD Anderson Cancer center
RECRUITINGLeague City, Texas, 77573, United States
-
MD Anderson Cancer center
RECRUITINGWoodland, Texas, 77384, United States
-
MedStar Washington Hospital Center
RECRUITINGWashington D.C., District of Columbia, 20010, United States
-
Montefiore Einstein Medical Center
RECRUITINGThe Bronx, New York, 10467, United States
-
Penn Medicine Princeton Medical Center
RECRUITINGPlainsboro, New Jersey, 08536, United States
-
Sibley Memorial Hospital
RECRUITINGWashington D.C., District of Columbia, 20016, United States
-
Smilow Cancer Hospital Care Center
RECRUITINGFairfield, Connecticut, 06824, United States
-
Smilow Cancer Hospital Care Center
RECRUITINGGuilford, Connecticut, 06437, United States
-
Smilow Cancer Hospital Care Center
RECRUITINGTrumbull, Connecticut, 06611, United States
-
Smilow Cancer Hospital Care Center
RECRUITINGWesterly, Rhode Island, 02891, United States
-
Smilow Cancer Hospital Care Center - Waterford
RECRUITINGWaterford, Connecticut, 06385, United States
-
Smilow Cancer Hospital Care Center at Greenwich
RECRUITINGGreenwich, Connecticut, 06830, United States
-
Smilow Cancer Hospital Care Center at Long Ridge
RECRUITINGStamford, Connecticut, 06901, United States
-
Smilow Cancer Hospital at Glastonbury
RECRUITINGGlastonbury, Connecticut, 06033, United States
-
Smilow Cancer Hospital at Saint Francis
RECRUITINGHartford, Connecticut, 06105, United States
-
Smilow Cancer Hospital-Derby Care Center
RECRUITINGDerby, Connecticut, 06418, United States
-
Smilow Cancer Hospital-Torrington Care Center
RECRUITINGTorrington, Connecticut, 06790, United States
-
Smilow Cancer Hospital-Waterbury Care Center
RECRUITINGWaterbury, Connecticut, 06708, United States
-
UNC Chapel Hill
RECRUITINGChapel Hill, North Carolina, 27599, United States
-
UPMC Hillman CC
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
-
University of California San Francisco Medical Center
RECRUITINGSan Francisco, California, 94143, United States
-
University of Chicago Comprehensive Cancer Center at Silver Cross
RECRUITINGNew Lenox, Illinois, 60451, United States
-
University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60637, United States
-
University of Chicago Medicine Northwest Indiana
RECRUITINGCrown Point, Indiana, 46307, United States
-
University of Chicago Medicine-Orland Park
RECRUITINGOrland Park, Illinois, 60462, United States
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
-
University of Washington - Fred Hutchinson Cancer Center
RECRUITINGSeattle, Washington, 98109, United States
-
Yale Cancer Center
RECRUITINGNew Haven, Connecticut, 06511, United States
-
Yale-New Haven Hospital North Haven Medical Center
RECRUITINGNew Haven, Connecticut, 06473, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could immune activators revive treatment for Hard-to-Treat breast cancer?
- DNA vaccine aims to train immune system against breast cancer
- New drug challenger takes on leading therapy for advanced breast cancer
- Spinal fluid may hold clues to breast cancer brain spread
- New cocktail of drugs aims to keep HER2+ breast cancer in check
- Kazakhstan cancer study to reveal Real-World treatment patterns